Katharina Kessel

PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

Robert Seifert, Katharina Kessel, Katrin Schlack et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 152 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving ¹⁷⁷Lu-PSMA-617 Radioligand Therapy

Robert Seifert, Konstantin Seitzer, Ken Herrmann et al. · Theranostics · 2020 · 135 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

Hojjat Ahmadzadehfar, Kambiz Rahbar, Richard P. Baum et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17

Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving ¹⁷⁷Lu-PSMA-617

Katharina Kessel, Robert Seifert, Michael Schäfers et al. · Theranostics · 2019 · 80 citations · Full text

Medicine, Oncology, Pharmacology +17

Monocyte‐Derived Interleukin‐1β As the Driver of S100A12‐Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease

Giulia Armaroli, Emely Verweyen, Carolin Pretzer et al. · Arthritis & Rheumatology · 2018 · 76 citations

Life Sciences, Cardiology, Immunology +17